
浏览全部资源
扫码关注微信
荆州市中心医院疼痛科,湖北 荆州 434000
主治医师,硕士。研究方向:脊柱退变。E-mail:zvrpnd@163.com
收稿:2025-08-25,
修回:2025-12-16,
录用:2025-12-17,
纸质出版:2026-01-15
移动端阅览
肖博文,彭聪,张森伟.基于FOXO3/Sirt1通路探讨槲皮素对腰椎间盘突出症大鼠椎间盘退变的影响 [J].中国药房,2026,37(01):49-54.
XIAO Bowen,PENG Cong,ZHANG Senwei.Exploration of the effects of quercetin on intervertebral disc degeneration in lumbar intervertebral disc herniation rats based on the FOXO3/Sirt1 pathway[J].ZHONGGUO YAOFANG,2026,37(01):49-54.
肖博文,彭聪,张森伟.基于FOXO3/Sirt1通路探讨槲皮素对腰椎间盘突出症大鼠椎间盘退变的影响 [J].中国药房,2026,37(01):49-54. DOI: 10.6039/j.issn.1001-0408.2026.01.09.
XIAO Bowen,PENG Cong,ZHANG Senwei.Exploration of the effects of quercetin on intervertebral disc degeneration in lumbar intervertebral disc herniation rats based on the FOXO3/Sirt1 pathway[J].ZHONGGUO YAOFANG,2026,37(01):49-54. DOI: 10.6039/j.issn.1001-0408.2026.01.09.
目的
2
研究槲皮素(QUE)对腰椎间盘突出症(LDH)大鼠椎间盘退变的影响,并基于叉头框蛋白O3/沉默信息调节因子1(FOXO3/Sirt1)通路探讨其作用机制。
方法
2
构建LDH大鼠模型,将造模成功的大鼠随机分为LDH组(灌胃+腹腔注射等体积生理盐水)、QUE-L组(灌胃50 mg/kg的QUE+腹腔注射等体积生理盐水)、QUE-H组(灌胃100 mg/kg的QUE+腹腔注射等体积生理盐水)、QUE-H+EX-527(Sirt1抑制剂)组(灌胃100 mg/kg的QUE+腹腔注射1 mg/kg的EX-527溶液),每组12只;另取12只正常健康大鼠作为Control组(灌胃+腹腔注射等体积生理盐水)。每天给药1次,连续8周。末次给药后,检测大鼠疼痛阈值、血清中炎症因子水平,观察大鼠椎间盘组织病理损伤,检测大鼠椎间盘组织髓核细胞凋亡情况,检测大鼠椎间盘组织中基质金属蛋白酶3(MMP-3)、磷脂酶A2(PLA2)以及凋亡、FOXO3/Sirt1通路相关蛋白表达。
结果
2
与LDH组比较,QUE-L组、QUE-H组大鼠椎间盘组织病理损伤显著改善;机械缩足反射阈值、热刺激缩足反射潜伏期,血清中转化生长因子β
1
、白细胞介素10(IL-10)水平,椎间盘组织中B细胞淋巴瘤2(Bcl-2)、FOXO3、Sirt1蛋白的相对表达量均显著升高/延长(
P
<0.05);血清中肿瘤坏死因子α、IL-1β水平,椎间盘组织病理评分,髓核细胞凋亡率,椎间盘组织中MMP-3、PLA2的阳性表达率和Bcl-2相关X蛋白的相对表达量均显著降低(
P
<0.05);与QUE-H组比较,QUE-H+EX-527组大鼠椎间盘组织病理损伤加重,以上指标的变化趋势均发生了显著逆转(
P
<0.05)。
结论
2
QUE可改善LDH大鼠椎间盘退变,其机制可能与激活FOXO3/Sirt1通路有关。
OBJECTIVE
2
To investigate the effects of quercetin (QUE) on intervertebral disc degeneration in rats with lumbar intervertebral disc herniation (LDH) and explore its mechanism based on the forkhead box protein O3/silent information regulator 1 (FOXO3/Sirt1) pathway.
METHODS
2
A rat model of LDH was established. The successfully modeled rats were randomly divided into LDH group (gavaged with and intraperitoneally injected with an equal volume of normal saline), QUE-L group (gavaged with 50 mg/kg QUE+intraperitoneally injected with an equal volume of normal saline), QUE-H group (gavaged with 100 mg/kg QUE+intraperitoneally injected with an equal volume of normal saline), and QUE-H+EX-527 (a Sirt1 inhibitor) group (gavaged with 100 mg/kg QUE+intraperitoneally injected with 1 mg/kg EX-527), with 12 rats in each group. Additionally, 12 healthy normal rats were selected as the control group (gavaged with and intraperitoneally injected with an equal volume of normal saline). All rats were administered the corresponding agents once daily for consecutive 8 weeks. After the final administration, the pain threshold and serum levels of inflammatory factors in rats were measured; pathological damage of lumbar intervertebral disc tissue was observed, the apoptosis of nucleus pulposus cells in lumbar intervertebral disc tissue was assessed, and the expression levels of matrix metalloproteinase-3 (MMP-3), phospholipase A2 (PLA2), as well as apoptosis-related proteins and FOXO3/Sirt1 pathway-related proteins in intervertebral disc tissue were determined.
RESULTS
2
Compared with LDH group, pathological damage of intervertebral disc tissue were improved significantly in QUE-L group and QUE-H group; paw withdrawal mechanical threshold, paw withdrawal thermal latency, the serum levels of transforming growth factor-β
1
and interleukin-10 (IL-10) as well as the expression levels of B-cell lymphoma-2 (Bcl-2), FOXO3 and Sirt1 were significantly increased or prolonged (
P
<0.05). Serum levels of tumor necrosis factor-α and IL-1β, histopathological score of intervertebral disc tissue, apoptotic rate of nucleus pulposus cells, positive expressions of MMP-3 and PLA2 in intervertebral disc tissue and expression levels of Bcl-2 associated X protein were significantly decreased (
P
<0.05). Compared with the QUE-H group, the QUE-H+EX-527 group presented aggravated pathological damage of intervertebral disc tissue, and the trends of all the above indicators were significantly reversed (
P
<0.05).
CONCLUSIONS
2
QUE can ameliorate intervertebral disc degeneration in LDH rats, and its mechanism may be related to the activation of the FOXO3/Sirt1 pathway.
ZHANG A S , XU A , ANSARI K , et al . Lumbar disc herniation:diagnosis and management [J ] . Am J Med , 2023 , 136 ( 7 ): 645 - 651 .
WONG T , PATEL A , GOLUB D , et al . Prevalence of long-term low back pain after symptomatic lumbar disc herniation [J ] . World Neurosurg , 2023 , 170 : 163 - 173.e1 .
SAMUELLY-LEICHTAG G , EISENBERG E , ZOHAR Y , et al . Mechanism underlying painful radiculopathy in patients with lumbar disc herniation [J ] . Eur J Pain , 2022 , 26 ( 6 ): 1269 - 1281 .
HAO Y J , REN Z N , YU L , et al . p300 arrests intervertebral disc degeneration by regulating the FOXO3/Sirt1/Wnt/β-catenin axis [J ] . Aging Cell , 2022 , 21 ( 8 ): e13677 .
WU X Y , PAN Q H , YAO C , et al . Therapeutic potential of quercitrin in intervertebral disc degeneration:targeting pyroptosis and inflammation [J ] . Int Immunopharmacol , 2025 , 156 : 114680 .
CUI Z F , ZHAO X T , AMEVOR F K , et al . Therapeutic application of quercetin in aging-related diseases:SIRT1 as a potential mechanism [J ] . Front Immunol , 2022 , 13 : 943321 .
王前亮 , 陈建澎 , 王元斌 , 等 . circ05188靶向miR-199a-5p参与腰椎间盘突出症模型大鼠痛觉高敏的机制 [J ] . 中国组织工程研究 , 2025 , 29 ( 20 ): 4230 - 4238 .
刘建 , 叶玉军 , 刘树民 , 等 . 基于p38 MAPK信号通路分析咪达唑仑对腰椎间盘突出症模型大鼠疼痛的影响 [J ] . 中国骨伤 , 2023 , 36 ( 1 ): 55 - 60 .
ZHANG S W , LIANG W D , ABULIZI Y , et al . Quercetin alleviates intervertebral disc degeneration by modulating p38 MAPK-mediated autophagy [J ] . Biomed Res Int , 2021 , 2021 : 6631562 .
安方玉 , 颜春鲁 , 孙柏 , 等 . 藤黄健骨胶囊通过SIRT1/NF-κB/NLRP3信号通路调节绝经后骨质疏松大鼠破骨细胞分化 [J ] . 中国病理生理杂志 , 2023 , 39 ( 11 ): 2044 - 2052 .
HINCAPIÉ C A , KROISMAYR D , HOFSTETTER L , et al . Incidence of and risk factors for lumbar disc herniation with radiculopathy in adults:a systematic review [J ] . Eur Spine J , 2025 , 34 ( 1 ): 263 - 294 .
XIA Q Q , ZHAO Y , DONG H Z , et al . Progress in the study of molecular mechanisms of intervertebral disc degeneration [J ] . Biomed Pharmacother , 2024 , 174 : 116593 .
CHEN X L , WANG W , CUI P , et al . Evidence of MRI image features and inflammatory biomarkers association with low back pain in patients with lumbar disc herniation [J ] . Spine J , 2024 , 24 ( 7 ): 1192 - 1201 .
GONG Y H , QIU J X , JIANG T , et al . Maltol ameliorates intervertebral disc degeneration through inhibiting PI3K/AKT/NF-κB pathway and regulating NLRP3 inflammasome-mediated pyroptosis [J ] . Inflammopharmacology , 2023 , 31 ( 1 ): 369 - 384 .
JIN Y M , MAO G F , YANG C , et al . Establishment of a new model of lumbar intervertebral disc degeneration with pathological characteristics [J ] . Global Spine J , 2023 , 13 ( 4 ): 984 - 994 .
LI Z H , TANG Y L , WANG L H , et al . Tetrahedral framework nucleic acids-based delivery of microRNA-155 alleviates intervertebral disc degeneration through targeting Bcl-2/Bax apoptosis pathway [J ] . Cell Prolif , 2024 , 57 ( 11 ): e13689 .
WANG P , YANG C C , LU J H , et al . Sirt1 protects against intervertebral disc degeneration induced by 1,25-dihydroxyvitamin D insufficiency in mice by inhibiting the NF-κB inflammatory pathway [J ] . J Orthop Translat , 2023 , 40 : 13 - 26 .
SHEN M K , LI K K , WANG L L , et al . ZIP4 upregulation aggravates nucleus pulposus cell degradation by promo- ting inflammation and oxidative stress by mediating the HDAC4-FoxO3a axis [J ] . Aging (Albany NY) , 2024 , 16 ( 1 ): 685 - 700 .
0
浏览量
11
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621